Armistice Capital, LLC 13D and 13G filings for Trevi Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 1:37 pm Purchase | 2022-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | Armistice Capital, LLC | 3,147,200 4.990% | 446,401 (+16.53%) | Filing |
| 2022-02-14 5:16 pm Purchase | 2021-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | Armistice Capital, LLC | 2,700,799 9.990% | 2,700,799 (New Position) | Filing |